The Danish life science industry has been characterized by job creation in the thousands and billions of kroner in exports. Now, it looks like Sweden wants to follow its lead.
The Stockholm region has a stated ambition for the Swedish capital to become one of the world's top five life science regions, and a new report from the Stockholm Chamber of Commerce points to investments in digitalization, clinical data and research as paths to reach that goal.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Long wait for IVDR implementation is over, putting an end to pandemic "wild west"
After prolonged debates on potential bottlenecking and supply issues, the EU’s long-awaited In Vitro Diagnostic Medical Devices Regulation comes into force on May 26.
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Bavarian Nordic upgrades guidance following vaccine contract
Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
Senior IT Network Engineer 
Account Manager 
Biomarker Operations Lead 
Senior Project Manager (GMP - Life Science) 
Strategic Procurement Manager, Direct Spend (Category Manager) 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Senior QA Specialist 
IRT Manager, Clinical Drug Supply 
Clinical Trial Manager 
Scientific Writer 
Senior Chemical Safety Advisor 
Key Account Manager, Europe and Asia 
Project Manager & Scrum Master 
Client Talent Acquisition Specialist 
Clinical Trial Manager for development of in vitro diagnostics